WB
RLAY icon

Webster Bank’s Relay Therapeutics RLAY Stock Holding History

Webster Bank’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7K Hold
1,000
– – ﹤0.01% 473
2026
Q1 		$9.95K Hold
1,000
– – ﹤0.01% 520
2025
Q4 		$8.46K Hold
1,000
– – ﹤0.01% 512
2025
Q3 		$5.22K Hold
1,000
– – ﹤0.01% 553
2025
Q2 		$3.46K Hold
1,000
– – ﹤0.01% 570
2025
Q1 		$2.62K Hold
1,000
– – ﹤0.01% 552
2024
Q4 		$4.12K Hold
1,000
– – ﹤0.01% 540
2024
Q3 		$7.08K Buy
+1,000
New +$7.47K ﹤0.01% 512

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Webster Bank's RLAY Position: Q2 2026 in Review

Webster Bank held its Relay Therapeutics (RLAY) position steady in Q2 2026 at 1,000 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #473.

Webster Bank first reported a position in RLAY in Q3 2024 and has held it in 8 quarters since. 260 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Webster Bank held 1,000 shares of Relay Therapeutics worth $18.7K as of Q2 2026.
  • Webster Bank left its Relay Therapeutics share count unchanged in Q2 2026.
  • Relay Therapeutics made up ﹤0.01% of Webster Bank's portfolio in Q2 2026, its #473 holding.
  • Webster Bank first reported a position in Relay Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 260 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Webster Bank's 13F filing for Q2 2026, filed 20 Jul 2026.